Root Cause Clinical Course · Module 4 of 10 · 4 lessons · 42 min

Insulin resistance and cardiometabolic risk

Learning objectives

  • Recognize insulin resistance and metabolic syndrome before diabetes develops.
  • Use ApoB, Lp(a) and coronary calcium to refine cardiovascular risk.
  • Combine lifestyle change and medication using outcome data.
Lesson 1 of 4

Spotting insulin resistance early

Insulin resistance can precede diabetes by a decade. Look for central weight gain, acanthosis nigricans, skin tags, PCOS, fatty liver, high triglycerides with low HDL, and a history of gestational diabetes.

MeasureThresholdNotes
A1c5.7 to 6.4% prediabetes; 6.5% or more diabetesLess reliable with anemia, recent transfusion, or some hemoglobin variants
Fasting glucose100 to 125 mg/dL prediabetes; 126 or more diabetesConfirm abnormal results
Metabolic syndrome3 of 5: waist over 40 in (men) or 35 in (women); TG 150+; HDL under 40 (men) or 50 (women); BP 130/85+; glucose 100+Raises cardiovascular and diabetes risk
Triglyceride to HDL ratioHigher ratios track with insulin resistanceCheap surrogate from a standard lipid panel
Fasting insulin and HOMA-IRHOMA-IR = glucose (mg/dL) x insulin (uIU/mL) / 405No standardized cutoff and assays vary; best for trends

Screen early. The ADA recommends testing all adults starting at age 35, and earlier in adults with overweight or obesity and a risk factor. Check liver health too: metabolic dysfunction-associated steatotic liver disease (MASLD) is common, and a FIB-4 score helps decide who needs elastography.

Lesson 2 of 4

Lipids beyond LDL

TestWhat it addsUse
ApoBCounts atherogenic particles (one ApoB per particle)Helpful when triglycerides are high or LDL seems falsely reassuring
Lp(a)Genetic, mostly fixed risk factorMeasure once in adulthood; 50 mg/dL (about 125 nmol/L) or higher is a risk enhancer
Non-HDL cholesterolAll atherogenic cholesterolFree from a standard panel; no fasting needed
hs-CRPInflammation2 mg/L or higher is a risk enhancer
Coronary artery calcium (CAC)Shows plaque directlyFor borderline or intermediate risk when the statin decision is unclear; a score of 0 lowers near-term risk

Estimate 10-year risk with the AHA PREVENT calculator, then use risk enhancers (family history, Lp(a), CRP, metabolic syndrome, chronic kidney disease, inflammatory disease, early menopause, preeclampsia) to guide shared decisions about statins.

Lesson 3 of 4

Lifestyle that moves the numbers

The Diabetes Prevention Program is the benchmark: about 7% weight loss plus 150 minutes a week of activity cut progression to diabetes by 58% (71% in adults 60 and older). Metformin cut it by 31%.

  • Resistance training two or more days a week improves insulin sensitivity independent of weight loss.
  • Walking after meals, even 10 to 15 minutes, lowers post-meal glucose.
  • Sleep under 6 hours worsens insulin sensitivity. Screen for sleep apnea.
  • Diet: fewer refined carbohydrates and sugary drinks, more fiber and protein. Lower-carbohydrate and Mediterranean patterns both work; adherence matters more than the label.
  • Continuous glucose monitors in people without diabetes can motivate change, but evidence for health outcomes is limited.
Lesson 4 of 4

Medications and when to use them

DrugKey evidence or roleCautions
MetforminConsider for prediabetes, especially BMI 35+, under 60, or prior gestational diabetesGI upset; check B12 over time
GLP-1 receptor agonists (semaglutide) and GIP/GLP-1 (tirzepatide)Weight loss of roughly 15 to 20%; semaglutide cut major cardiovascular events 20% in people with CVD and obesity (SELECT)Not for personal or family history of medullary thyroid cancer or MEN2; GI effects; muscle loss; use FDA-approved products
SGLT2 inhibitorsHeart failure and kidney protectionGenital infections; rare euglycemic ketoacidosis
StatinsFirst-line for elevated risk per guidelinesMuscle symptoms are often not caused by the statin; consider rechallenge or another statin

Medication and lifestyle work together. GLP-1 users who keep up protein intake and strength training preserve more muscle, and those who stop the drug usually regain weight unless habits have changed.

Clinical pearls

  • Triglycerides over 150 with a low HDL are an insulin resistance clue on a routine panel.
  • Order Lp(a) once. It is largely genetic, and a high result changes how aggressive you should be with other risk factors.
  • Use HOMA-IR to track a patient over time, not to diagnose.

Red flags: refer or work up first

  • Glucose over 250 mg/dL with symptoms, weight loss, or ketones: evaluate the same day for diabetes needing insulin or DKA.
  • LDL 190 mg/dL or higher: consider familial hypercholesterolemia and screen relatives.
  • Chest pain, exertional shortness of breath or claudication: evaluate for vascular disease before starting an exercise plan.

Case

A 52-year-old woman has an A1c of 6.1%, triglycerides of 210, HDL of 38, a waist of 39 inches, and LDL of 118. Her father had a heart attack at 50.

Show discussion

She has prediabetes and metabolic syndrome. Plan DPP-style lifestyle change (about 7% weight loss, 150 minutes of activity, strength training), check Lp(a) and ApoB, and estimate risk with PREVENT. With the family history and metabolic syndrome as risk enhancers, discuss a statin or a CAC score to guide that decision. Consider metformin or GLP-1 therapy if weight or glucose don't improve.

Question 1: In the Diabetes Prevention Program, lifestyle change reduced progression to diabetes by about:

Question 2: How often should most adults have Lp(a) measured?

References
  • Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002.
  • American Diabetes Association. Standards of Care in Diabetes (current edition), sections 2 and 3.
  • Grundy SM, et al. Diagnosis and management of the metabolic syndrome: AHA/NHLBI Scientific Statement. Circulation. 2005.
  • Grundy SM, et al. 2018 AHA/ACC Guideline on the Management of Blood Cholesterol. Circulation. 2019.
  • Khan SS, et al. Development and validation of the American Heart Association's PREVENT equations. Circulation. 2024.
  • Lincoff AM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT). N Engl J Med. 2023.
  • Rinella ME, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023.
Patient handout · plain language

Blood sugar and your heart

Insulin resistance means your body has to work harder to keep blood sugar normal. It often comes before diabetes and raises heart risk. The good news: it responds well to change.

  • Walk for 10 to 15 minutes after meals.
  • Do strength exercises (like squats, wall push-ups or bands) twice a week.
  • Swap sugary drinks for water, and add protein and fiber to meals.
  • Aim for 7 or more hours of sleep. Loud snoring is worth mentioning to us.
  • Losing even 5 to 7% of your weight can lower your risk a lot.

Numbers to know: your A1c, blood pressure, and cholesterol. Ask us what yours are.

General education for licensed clinicians and the public. Not medical advice, and not a substitute for clinical judgment, current guidelines, or a visit with a licensed provider. Product names are examples, not endorsements. Drug doses, coding rules and guidance change; check current labeling, payer rules and guidelines before acting. Book a visit with Empowered Health.